awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38246587-6218C626-BE53-4C39-8B80-DE85C24FC126
Q38246587-6218C626-BE53-4C39-8B80-DE85C24FC126
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38246587-6218C626-BE53-4C39-8B80-DE85C24FC126
PSA response rate as a surrogate marker for median overall survival in docetaxel-based first-line treatments for patients with metastatic castration-resistant prostate cancer: an analysis of 22 trials.
P2860
Q38246587-6218C626-BE53-4C39-8B80-DE85C24FC126
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38246587-6218C626-BE53-4C39-8B80-DE85C24FC126
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7bd6f5a542e88be9a8a39bbdd4aadefa9309a9cc
P2860
2-Weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial.